Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program DIABETOLOGIA Matthews, D. R., Li, Q., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Desai, M., Hiatt, W. R., Nehler, M., Fabbrini, E., Kavalam, M., Lee, M., Neal, B. 2019; 62 (6): 926–38

View details for DOI 10.1007/s00125-019-4839-8

View details for Web of Science ID 000467640700006